Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Chemical strategies for activating PINK1, a protein kinase mutated in Parkinson's Disease

Lambourne, Olivia A. and Mehellou, Youcef 2018. Chemical strategies for activating PINK1, a protein kinase mutated in Parkinson's Disease. ChemBioChem 19 (23) , pp. 2433-2437. 10.1002/cbic.201800497

PDF - Accepted Post-Print Version
Download (814kB) | Preview


PINK1 is a ubiquitously expressed mitochondrial serine/threonine protein kinase that has emerged as a key player in mitochondrial quality control. This protein kinase came to prominence in the mid‐2000s, when PINK1 mutations were found to cause early onset Parkinson's disease (PD). As most of the PD‐related mutations occurred in the kinase domain and impaired PINK1′s catalytic activity, it was suggested that small molecules that activated PINK1 would maintain mitochondrial quality control and, as a result, have neuroprotective effects. Working on this hypothesis, a few small‐molecule PINK1 activators that offer critical insights and distinct approaches for activating PINK1 have been discovered. Herein, we briefly highlight the discovery of these small molecules and offer insight into the future development of small‐molecule PINK1 activators as potential treatments for PD.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Pharmacy
Publisher: Wiley: 12 months
ISSN: 1439-4227
Date of First Compliant Deposit: 1 October 2018
Date of Acceptance: 24 September 2018
Last Modified: 24 Sep 2019 02:09

Citation Data

Cited 1 time in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item